Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Plasma Cell Dyscrasias Test
Comprehensive Diagnostic Testing for Blood Cancers
Immunophenotyping by Flow Cytometry represents a cornerstone in modern hematologic diagnostics, providing essential information for the accurate classification and management of leukemia and plasma cell disorders. This advanced diagnostic panel utilizes sophisticated technology to analyze cell surface markers, enabling precise identification of abnormal cell populations that characterize various hematologic malignancies.
What This Test Measures and Detects
This comprehensive diagnostic panel evaluates multiple cellular markers to provide detailed characterization of abnormal blood cells:
- Identification of leukemia subtypes including acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), and other hematologic malignancies
- Detection and characterization of plasma cell dyscrasias including multiple myeloma and related disorders
- Analysis of cell surface antigens including CD markers, immunoglobulin light chains, and other critical diagnostic markers
- Assessment of abnormal cell populations in peripheral blood and bone marrow samples
- Quantification of minimal residual disease following treatment
Who Should Consider This Test
This diagnostic panel is recommended for individuals experiencing symptoms or clinical findings suggestive of hematologic malignancies:
- Patients with unexplained cytopenias (low blood counts) including anemia, thrombocytopenia, or neutropenia
- Individuals with abnormal peripheral blood smear findings or suspicious circulating cells
- Patients with bone marrow abnormalities detected during evaluation
- Those with symptoms including unexplained fatigue, recurrent infections, easy bruising or bleeding, bone pain, or unexplained weight loss
- Individuals with monoclonal gammopathy of undetermined significance (MGUS) requiring further evaluation
- Patients requiring monitoring of treatment response or disease progression
Key Benefits of Immunophenotyping Testing
Choosing this advanced diagnostic panel provides numerous clinical advantages:
- Accurate Diagnosis: Precise classification of leukemia subtypes and plasma cell disorders enables targeted treatment approaches
- Treatment Guidance: Results help oncologists select appropriate chemotherapy regimens and targeted therapies
- Prognostic Information: Specific marker patterns provide valuable prognostic information for treatment planning
- Minimal Residual Disease Monitoring: Sensitive detection of residual disease following treatment
- Comprehensive Analysis: Simultaneous evaluation of multiple cell populations and markers
- Rapid Results: Same-day reporting when samples are received by 9 AM
Understanding Your Test Results
Your immunophenotyping results will provide detailed information about cell populations and their characteristic markers:
- Normal Results: Indicate no abnormal cell populations detected, suggesting no evidence of hematologic malignancy
- Abnormal Patterns: Specific marker combinations help identify particular leukemia subtypes or plasma cell disorders
- Quantitative Data: Results include percentages of abnormal cells and their characteristic marker profiles
- Clinical Correlation: Results should be interpreted in conjunction with clinical findings, morphology, and other laboratory tests
- Follow-up Recommendations: Your healthcare provider will discuss appropriate next steps based on the findings
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $250 |
| Regular Price | $376 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network ensures accessible, high-quality diagnostic services for patients nationwide.
Schedule Your Test Today
Take the first step toward accurate diagnosis and personalized treatment planning. Our experienced team is ready to assist you with scheduling and answer any questions about the testing process. Contact us today to book your Immunophenotyping by Flow Cytometry Leukemia Diagnostic Panel Plasma Cell Dyscrasias Test.
Call or WhatsApp: +1(267) 388-9828
Remember to bring your clinical history and any relevant medical records to your appointment. Our specialized flow cytometry laboratory processes samples daily with same-day reporting available when specimens are received by 9 AM.
